B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab (NCT03982992) | Ludwig-Maximilians - University of Munich | 2019-06-01 |
Track B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation automatically
Every clearance here is in the API, with alerts when new ones post.